Page 21 - Synlogic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation.

Synlogic (NASDAQ:SYBX – Get Rating)‘s stock had its “buy” rating reaffirmed by equities researchers at Oppenheimer in a research report issued on Friday, TipRanks reports. They presently have a $7.00 target price on the biotechnology company’s stock. Oppenheimer’s target price suggests a potential upside of 213.90% from the stock’s current price. A number of other […]

Synlogic (NASDAQ:SYBX – Get Rating) had its price objective cut by stock analysts at SVB Leerink from $11.00 to $8.00 in a report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the biotechnology company’s stock. SVB Leerink’s target price points to a potential upside of 292.16% from the company’s previous […]

These members bring extensive experience to PreciseDx and its mission to improve cancer patient outcomes through AI-enabled technologyNEW YORK, Ma...

Zacks Investment Research cut shares of Synlogic (NASDAQ:SYBX – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, “Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and […]